preview

Project Proposal: Prevnar Vaccination

Decent Essays

The Advisory Committee on Immunization Practices (2012), recommends Prevnar vaccination for subjects aged ≥65 y and for those aged 50–64 y at high risk for specific health conditions, such as diabetes, cardiovascular diseases, nephropathies, hypertension and chronic obstructive pulmonary disease (Assaad, El-Masri, Porhomayon, & El-Solh, 2012). For the purpose of launching the scholarly project, I chose the 50 and over adult population ( with comorbid conditions including asthma, COPD and diabetes) because this is the identified patient population who are mostly unaware about the need for Prevnar vaccination.
Intervention
There are existing data in literature stating that vaccine reminders and education were associated with greater

Get Access